Finance
FDA Slashes Drug Approval Time by 2 Months
The FDA has significantly reduced drug approval times, cutting average reviews by up to two months. This efficiency drive, aided by AI, aims to bring life-saving treatments to patients faster without compromising safety. Pharmaceutical companies are set to benefit from quicker market access and potentially lower R&D costs.